CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Perspective of Small-Molecule AdipoR Agonist for Type 2 Diabetes and Short Life in Obesity
Miki Okada-Iwabu, Masato Iwabu, Kohjiro Ueki, Toshimasa Yamauchi, Takashi Kadowaki
Diabetes Metab J. 2015;39(5):363-372.   Published online October 22, 2015
DOI: https://doi.org/10.4093/dmj.2015.39.5.363

Excel Download

Perspective of Small-Molecule AdipoR Agonist for Type 2 Diabetes and Short Life in Obesity
Diabetes & Metabolism Journal. 2015;39(5):363   Crossref logo
Link1 Link2 Link3

A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity
Nature. 2013;503(7477):493-499   Crossref logo
Link1 Link2 Link3

The role of small molecule GPR119 agonist, AS1535907, in glucose-stimulated insulin secretion and pancreatic β-cell function
Diabetes, Obesity and Metabolism. 2010;13(1):34-41   Crossref logo
Link1 Link2

Obesity, type 2 diabetes and cardiovascular disease
Western Diseases. 2001;23-49   Crossref logo
Link1

339-OR: Oral Small-Molecule GLP-1R Agonist Danuglipron Robustly Reduces Plasma Glucose and Body Weight after Eight Weeks in Japanese Adults with Type 2 Diabetes Mellitus
Diabetes. 2022;71(Supplement_1):   Crossref logo
Link1 Link2

94-LB: A Phase 1, Double-Blind, Placebo-Controlled Multiple Escalating Dose Study of RGT-075 Novel Small-Molecule Oral GLP-1 Receptor Agonist in Adults with Type 2 Diabetes
Diabetes. 2022;71(Supplement_1):   Crossref logo
Link1 Link2

Anti-obesity effects of small molecule melanin-concentrating hormone receptor1 (MCHR1) antagonists
Life Sciences. 2007;81(6):423-440   Crossref logo
Link1 Link2

Design, synthesis chalcone derivatives as AdipoR agonist for type 2 diabetes
Chemical Biology & Drug Design. 2018;92(2):1525-1536   Crossref logo
Link1 Link2 Link3 Link4

Lixisenatide, a novel GLP-1 receptor agonist: efficacy, safety and clinical implications for type 2 diabetes mellitus
Diabetes, Obesity and Metabolism. 2014;16(7):588-601   Crossref logo
Link1 Link2

Cardiovascular effects of glucagon-like peptide-1 receptor agonist therapies in patients with type 1 diabetes
Diabetes, Obesity and Metabolism. 2017;19(5):613-614   Crossref logo
Link1 Link2